The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer
Official Title: Open Label Study of the Effect of GTx-758 on Serum PSA and Free Testosterone Levels in Men With Castration Resistant Prostate Cancer and Maintained on Androgen Deprivation Therapy
Study ID: NCT01420861
Brief Summary: The purpose of this study is to assess the effect of GTx-758 on Serum Prostate-specific antigen (PSA) levels in men with castrate resistant prostate cancer who are maintained on androgen deprivation therapy (Serum PSA response and Serum PSA progression)
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
GTx Investigative Site, San Bernardino, California, United States
GTx Investigational Site, Jeffersonville, Indiana, United States
GTx Investigative Site, Albuquerque, New Mexico, United States
GTx Investigative Site, Syracuse, New York, United States
GTx Investigative Site, Bala-Cynwyd, Pennsylvania, United States
GTx Investigative Site, San Antonio, Texas, United States
GTx Investigative Site, Virginia Beach, Virginia, United States
Name: Mitchell Steiner, MD
Affiliation: GTx
Role: STUDY_DIRECTOR